A 45-year-old man with uncontrolled diabetes mellitus presents with severe left periorbital edema, proptosis, and complete ophthalmoplegia over 3 days. He has fever (38.5°C), headache, and chemosis. MRI orbit shows diffuse retrobulbar inflammation with early abscess formation. Blood glucose is 380 mg/dL. What is the most appropriate next step in management?

Explanation

## Orbital Cellulitis with Abscess: Surgical Urgency ### Clinical Context: Diabetic Patient with Orbital Abscess **Key Point:** The presence of an abscess cavity on imaging is an absolute indication for surgical drainage. Antibiotics alone cannot penetrate purulent collections adequately. ### Imaging Findings and Management Correlation | Finding | Management | |---------|------------| | **Retrobulbar inflammation only (no abscess)** | IV antibiotics; close imaging follow-up | | **Early/small abscess (<1 cm)** | IV antibiotics ± close observation (some centers) | | **Established abscess (>1 cm) or rapid progression** | **Immediate surgical drainage + IV antibiotics** | | **Cavernous sinus involvement** | Urgent drainage + IV antibiotics | **High-Yield:** Once an abscess is identified on CT/MRI, surgical drainage is mandatory. Antibiotic monotherapy fails in >50% of cases with documented abscess. ### Why This Patient Requires Immediate Surgery 1. **Documented abscess on MRI** — antibiotics alone cannot achieve adequate drug penetration into purulent fluid 2. **Complete ophthalmoplegia** — indicates severe orbital compartment involvement and risk of vision loss 3. **Rapid progression over 3 days** — suggests aggressive infection with high risk of cavernous sinus thrombosis 4. **Uncontrolled diabetes** — impairs immune response and increases infection severity ### Management Algorithm for Orbital Abscess ```mermaid flowchart TD A[Orbital cellulitis with fever/proptosis]:::outcome --> B[CT/MRI orbit]:::action B --> C{Abscess present?}:::decision C -->|No| D[IV antibiotics only]:::action C -->|Yes| E[Surgical drainage]:::urgent E --> F[Intraoperative culture & sensitivity]:::action F --> G[IV ceftriaxone + vancomycin]:::action G --> H[Adjust antibiotics per culture at 48-72 hrs]:::action H --> I[Clinical improvement & imaging resolution]:::outcome ``` **Clinical Pearl:** Diabetic patients are at higher risk for severe, rapidly progressive orbital infections and mucormycosis. However, in this case, the acute presentation with bacterial cellulitis and abscess formation is more consistent with Staphylococcus aureus or Streptococcus species than with mucormycosis (which typically presents with tissue necrosis and rapid vision loss). ### Concurrent Management: Glucose Control **Key Point:** Aggressive blood glucose control (target <200 mg/dL) is essential to optimize immune function, but it is adjunctive to surgical drainage and antibiotics — not a substitute. ### Why Amphotericin B Is Not First-Line Here - **Mucormycosis** presents with tissue necrosis, black eschar, and fulminant progression with rapid blindness - This patient has acute bacterial cellulitis with abscess — no clinical or imaging features of invasive fungal disease - Amphotericin B is reserved for confirmed or highly suspected mucormycosis (e.g., necrotic tissue, sinus involvement, immunocompromised state) [cite:Kanski Clinical Ophthalmology 9e Ch 3; Orbit Surgery textbooks]